Nordea Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $947M | Buy |
4,382,783
+232,824
| +6% | +$51.6M | 0.88% | 18 |
|
|
2025
Q4 | $951M | Sell |
4,149,959
-345,599
| -8% | -$78.7M | 0.82% | 19 |
|
|
2025
Q3 | $1.01B | Buy |
4,495,558
+6,081
| +0.1% | +$1.24M | 0.89% | 18 |
|
|
2025
Q2 | $834M | Buy |
4,489,477
+409,190
| +10% | +$76M | 0.77% | 24 |
|
|
2025
Q1 | $856M | Buy |
4,080,287
+1,086,553
| +36% | +$211M | 0.9% | 18 |
|
|
2024
Q4 | $529M | Buy |
2,993,734
+483,455
| +19% | +$88.9M | 0.55% | 36 |
|
|
2024
Q3 | $493M | Sell |
2,510,279
-1,243,892
| -33% | -$232M | 0.56% | 39 |
|
|
2024
Q2 | $637M | Sell |
3,754,171
-356,560
| -9% | -$59.1M | 0.75% | 25 |
|
|
2024
Q1 | $746M | Sell |
4,110,731
-290,261
| -7% | -$50M | 0.88% | 20 |
|
|
2023
Q4 | $682M | Sell |
4,400,992
-158,702
| -3% | -$23.1M | 0.87% | 23 |
|
|
2023
Q3 | $689M | Buy |
4,559,694
+255,343
| +6% | +$37.5M | 0.96% | 20 |
|
|
2023
Q2 | $573M | Buy |
4,304,351
+559,962
| +15% | +$82.1M | 0.78% | 23 |
|
|
2023
Q1 | $592M | Buy |
3,744,389
+77,101
| +2% | +$11.8M | 0.86% | 22 |
|
|
2022
Q4 | $591M | Sell |
3,667,288
-25,617
| -0.7% | -$3.93M | 0.92% | 19 |
|
|
2022
Q3 | $507M | Sell |
3,692,905
-113,006
| -3% | -$16.2M | 0.82% | 24 |
|
|
2022
Q2 | $578M | Sell |
3,805,911
-211,602
| -5% | -$32.3M | 0.86% | 27 |
|
|
2022
Q1 | $658M | Buy |
4,017,513
+162,631
| +4% | +$23.6M | 0.83% | 30 |
|
|
2021
Q4 | $522M | Buy |
3,854,882
+200,553
| +5% | +$23.7M | 0.63% | 36 |
|
|
2021
Q3 | $402M | Sell |
3,654,329
-19,441
| -0.5% | -$2.22M | 0.52% | 53 |
|
|
2021
Q2 | $414M | Buy |
3,673,770
+237,573
| +7% | +$26.8M | 0.55% | 45 |
|
|
2021
Q1 | $370M | Sell |
3,436,197
-136,528
| -4% | -$14.6M | 0.54% | 45 |
|
|
2020
Q4 | $383M | Buy |
3,572,725
+354,815
| +11% | +$34.1M | 0.61% | 41 |
|
|
2020
Q3 | $280M | Sell |
3,217,910
-2,746,716
| -46% | -$259M | 0.52% | 54 |
|
|
2020
Q2 | $574M | Buy |
5,964,626
+3,560,895
| +148% | +$314M | 0.6% | 44 |
|
|
2020
Q1 | $183M | Buy |
2,403,731
+111,833
| +5% | +$9.53M | 0.44% | 58 |
|
|
2019
Q4 | $203M | Sell |
2,291,898
-8,461
| -0.4% | -$702K | 0.4% | 63 |
|
|
2019
Q3 | $173M | Buy |
2,300,359
+203,616
| +10% | +$14M | 0.38% | 71 |
|
|
2019
Q2 | $153M | Sell |
2,096,743
-59,686
| -3% | -$4.69M | 0.34% | 73 |
|
|
2019
Q1 | $174M | Buy |
2,156,429
+131,026
| +6% | +$10.7M | 0.36% | 69 |
|
|
2018
Q4 | $187M | Buy |
2,025,403
+156,798
| +8% | +$13.8M | 0.44% | 58 |
|
|
2018
Q3 | $177M | Sell |
1,868,605
-58,523
| -3% | -$5.55M | 0.36% | 71 |
|
|
2018
Q2 | $179M | Buy |
1,927,128
+252,969
| +15% | +$24.7M | 0.43% | 63 |
|
|
2018
Q1 | $158M | Sell |
1,674,159
-30,621
| -2% | -$3.36M | 0.38% | 71 |
|
|
2017
Q4 | $165M | Sell |
1,704,780
-444,183
| -21% | -$41.9M | 0.39% | 63 |
|
|
2017
Q3 | $191M | Sell |
2,148,963
-1,109,237
| -34% | -$84.4M | 0.46% | 56 |
|
|
2017
Q2 | $236M | Sell |
3,258,200
-234,952
| -7% | -$15.8M | 0.6% | 44 |
|
|
2017
Q1 | $228M | Sell |
3,493,152
-42,997
| -1% | -$2.7M | 0.6% | 44 |
|
|
2016
Q4 | $221M | Sell |
3,536,149
-33,515
| -0.9% | -$2.05M | 0.59% | 46 |
|
|
2016
Q3 | $225M | Buy |
3,569,664
+118,328
| +3% | +$7.66M | 0.58% | 43 |
|
|
2016
Q2 | $214M | Buy |
3,451,336
+63,274
| +2% | +$3.86M | 0.6% | 42 |
|
|
2016
Q1 | $194M | Buy |
3,388,062
+292,553
| +9% | +$16.3M | 0.58% | 47 |
|
|
2015
Q4 | $183M | Buy |
3,095,509
+134,947
| +5% | +$7.77M | 0.62% | 46 |
|
|
2015
Q3 | $161M | Buy |
2,960,562
+100,434
| +4% | +$6.54M | 0.59% | 51 |
|
|
2015
Q2 | $192M | Buy |
2,860,128
+34,333
| +1% | +$2.24M | 0.67% | 45 |
|
|
2015
Q1 | $165M | Buy |
2,825,795
+923,554
| +49% | +$55.8M | 0.59% | 49 |
|
|
2014
Q4 | $124M | Buy |
1,902,241
+1,340
| +0.1% | +$84.5K | 0.46% | 59 |
|
|
2014
Q3 | $110M | Buy |
1,900,901
+149,351
| +9% | +$8.29M | 0.44% | 60 |
|
|
2014
Q2 | $98.9M | Buy |
1,751,550
+95,253
| +6% | +$5M | 0.41% | 67 |
|
|
2014
Q1 | $85.1M | Sell |
1,656,297
-29,857
| -2% | -$1.51M | 0.4% | 62 |
|
|
2013
Q4 | $89M | Sell |
1,686,154
-59,715
| -3% | -$2.93M | 0.44% | 56 |
|
|
2013
Q3 | $78.1M | Buy |
1,745,869
+313,654
| +22% | +$13.9M | 0.44% | 56 |
|
|
2013
Q2 | $59.2M | Buy |
+1,432,215
| New | +$62.6M | 0.37% | 71 |
|
Other funds holding ABBV
VCM
VPM
Nordea Investment Management's ABBV Position: Q1 2026 in Review
Nordea Investment Management increased its AbbVie (ABBV) stake by 5.6% in Q1 2026, buying an estimated $51.6M and bringing the position to 4,382,783 shares worth $947M. The position accounts for 0.88% of the portfolio, ranked #18.
Nordea Investment Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.01B in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Nordea Investment Management held 4,382,783 shares of AbbVie worth $947M as of Q1 2026.
- Nordea Investment Management bought 232,824 AbbVie shares in Q1 2026, an estimated $51.6M.
- AbbVie made up 0.88% of Nordea Investment Management's portfolio in Q1 2026, its #18 holding.
- Nordea Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Nordea Investment Management's AbbVie position peaked at $1.01B in Q3 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.